ArticlePloS one2026

Feasibility of the Xemio app for breast cancer survivors in a clinical setting: Adherence, acceptance, and side effect monitoring (CTCAE vs. QoL).

Maria-Angeles Fuentes-Expósito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.